Abstract
Dithiocarbamates represent a class of compounds that were evaluated in different biomedical applications because of their chemical versatility. For this reason, several pharmacological activities have already been attributed to these compounds, such as antiparasitic, antiviral, antifungal activities, among others. Therefore, compounds that are based on dithiocarbamates have been evaluated in different in vivo and in vitro models as potential new antimicrobials. Thus, the purpose of this review is to present the possibilities of using dithiocarbamate compounds as potential new antitrypanosomatids-drugs, which could be used for the pharmacological control of Chagas disease, leishmaniasis, and African trypanosomiasis.
| Original language | English |
|---|---|
| Pages (from-to) | E2806-E2820 |
| Number of pages | 14 |
| Journal | Molecules |
| Volume | Vol. 24 |
| Issue number | n.º 15 |
| DOIs | |
| Publication status | Published - 1 Aug 2019 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- African trypanosomiasis
- Chagas disease
- DETC
- Trypanosomatids
- Antiparasitic activity
- Dithiocarbamates
- Leishmaniasis
Fingerprint
Dive into the research topics of 'Application of Dithiocarbamates as potential new antitrypanosomatids-drugs: approach chemistry, functional and biological'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver